Ida Rosenkrands

Ida Rosenkrands

Auto-generated profile, based on publicly available information

Ida Rosenkrands

Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2002 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
IRIda Rosenkrands
Ida Rosenkrands
RSRichard A. Slayden
Richard A. Slayden
JCJanne Crawford
Janne Crawford
CAClaus Aagaard
Claus Aagaard
CBClifton E. Barry
Clifton E. Barry
PAPeter Andersen
Peter Andersen
The events involved in the establishment of a latent infection withMycobacterium tuberculosisare not fully understood, but hypoxic conditions are generally believed to be the environment encountered by the pathogen in the central part of the granuloma. The present study was undertaken to provide insight intoM. tuberculosisprotein expression in in vitro latency models where oxygen is depleted. The response ofM. tuberculosisto low-oxygen conditions was investigated in both cellular and extracellular proteins by metabolic labeling, two-dimensional electrophoresis, and protein signature peptide analysis by liquid chromatography-mass spectrometry. By peptide mass fingerprinting and immunodetection, five proteins more abundant under low-oxygen conditions were identified from several lysates ofM. tuberculosis: Rv0569, Rv2031c (HspX), Rv2623, Rv2626c, and Rv3841 (BfrB). InM. tuberculosisculture filtrates, two additional proteins, Rv0363c (Fba) and Rv2780 (Ald), were found in increased amounts under oxygen limitation. These results extend our understanding of the hypoxic response inM. tuberculosisand potentially provide important insights into the physiology of the latent bacilli.

1 May 2013 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
JAJakob Albrethsen
Jakob Albrethsen
JAJeppe Agner
Jeppe Agner
SPSander R. Piersma
Sander R. Piersma
PHPeter Hojrup
Peter Hojrup
TPThang V. Pham
Thang V. Pham
IRIda Rosenkrands
Ida Rosenkrands
In order to successfully enter the latent stage, Mycobacterium tuberculosis must adapt to conditions such as nutrient limitation and hypoxia. In vitro models that mimic latent infection are valuable tools for describing the changes in metabolism that occur when the bacterium exists in a non-growing form. We used two complementary proteomic approaches, label-free LC-MS/MS analysis and two-dimensional difference gel electrophoresis, to determine the proteome profile of extracellular proteins from M. tuberculosis cultured under nutrient starvation. Through the label-free LC-MS/MS analysis of fractionated samples, 1176 proteins were identified from culture filtrates of log phase and nutrient-starved cultures, and the protein levels of 230 proteins were increased in nutrient-starved culture filtrates, whereas those of 208 proteins were decreased. By means of Gene Ontology clustering analysis, significant differences in the overall metabolism during nutrient starvation were detected. Notably, members of the toxin–antitoxin systems were present in larger quantities in nutrient-starved cultures, supporting a role for these global modules as M. tuberculosis switches its metabolism into dormancy. Decreased abundance of proteins involved in amino acid and protein synthesis was apparent, as well as changes in the lipid metabolism. Further analysis of the dataset identified increased abundance of lipoproteins and decreased abundance of ESAT-6 family proteins. Results from the two-dimensional difference gel electrophoresis proteomics demonstrated overall agreement with the LC-MS/MS data and added complementary insights about protein degradation and modification.

1 August 2011 in Vaccine
Verified
Journal Article
Closed access
IRIda Rosenkrands
Ida Rosenkrands
CVCarina Vingsbo-Lundberg
Carina Vingsbo-Lundberg
TBTrine Junker Bundgaard
Trine Junker Bundgaard
TLThomas Lindenstrøm
Thomas Lindenstrøm
VEVincent Enouf
Vincent Enouf
EAElse Marie Agger
Else Marie Agger

1 December 2016 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
OØOle Østergaard
Ole Østergaard
FFFrank Follmann
Frank Follmann
AOAnja W. Olsen
Anja W. Olsen
NHNiels H. Heegaard
Niels H. Heegaard
PAPeter Andersen
Peter Andersen
IRIda Rosenkrands
Ida Rosenkrands
Chlamydia trachomatis is one of the most common sexually transmitted bacterial pathogens in humans. The infection is often asymptomatic and can lead to chronic manifestations. The infectious elementary body and the replicating reticulate body are the two growth forms in the normal developmental cycle. Under the influence of interferon-γ, the normal cycle is disrupted because of tryptophan degradation, leading to a third persistent form, the aberrant reticulate body. For the genital strain C. trachomatis D/UW-3/CX we established a quantitative, label-free proteomic approach, and identified in total 655 out of 903 (73%) predicted proteins, allowing the first quantitative comparison of all three growth forms. Inclusion membrane proteins and proteins involved in translation were more abundant in the reticulate body (RB)1 1The abbreviations used are: RBReticulate bodyANOVAAnalysis of varianceARBAberrant reticulate bodyCVCoefficient of variationEBElementary bodyFDRFalse discovery rateiBAQIntensity-based absolute quantificationIDOIndoleamine 2,3-dioxygenaseIFN-γInterferon-γIncprotein Inclusion membrane proteinMOMPMajor outer membrane proteinMS1Full scan mass spectrumOmcBCysteine-rich, outer membrane complex protein BPmpPolymorphic membrane proteinT3SSType 3 secretion systemTrpTryptophanTrpATryptophan synthase subunit ATrpBTryptophan synthase subunit B. and aberrant reticulate body (ARB) forms, whereas proteins of the type III Secretion System and the cell envelope were more abundant in the elementary body (EB) form, reflecting the need for these proteins to establish infection and for host interactions. In the interferon-γ induced ARB proteome, the tryptophan synthase subunits were identified as biomarkers with a strong increase from less than 0.05% to 9% of the total protein content, reflecting an inherent defense strategy for the pathogen to escape interferon-γ mediated immune pressure. Furthermore, the total tryptophan content in the ARB form was 1.9-fold lower compared with the EB form, and we demonstrate that modulation of the protein repertoire toward lower abundance of proteins with high tryptophan content, is a mechanism which contributes to establish and maintain chlamydial persistence. Thus, quantitative proteomics provides insights in the Chlamydia defense mechanisms to escape interferon-γ mediated immune pressure.

23 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
AOAnja W. Olsen
Anja W. Olsen
IRIda Rosenkrands
Ida Rosenkrands
CJChristina S. Jacobsen
Christina S. Jacobsen
HCHannah M Cheeseman
Hannah M Cheeseman
MKMax P. Kristiansen
Max P. Kristiansen
FFFrank Follmann
Frank Follmann
The clinical development of an effective Chlamydia vaccine requires in-depth understanding of how well protective pre-clinical immune signatures translate to humans. Here, we report a comparative immunological characterization of CTH522/CAF®01 in female mice and humans. We find a range of immune signatures that translate from mouse to human, including a Th1/Th17 cytokine profile and antibody functionality. We identify vaccine-induced T cell epitopes, conserved among Chlamydia serovars, and previously found in infected individuals. Using the mouse model, we show that the common immune signature protected against ascending infection in mice, and vaccine induced antibodies could delay bacterial ascension to the oviduct, as well as development of pathology, in a T cell depleted mouse model. Finally, we demonstrate long-lasting immunity and protection of mice one year after vaccination. Based on the results obtained in the present study, we propose to further investigate CTH522/CAF®01 in a phase IIb study.

19 April 2021 in npj Vaccines
Verified
Journal Article
Open access
PDF file
AOAnja Weinreich Olsen
Anja Weinreich Olsen
IRIda Rosenkrands
Ida Rosenkrands
Martin HollandMartin Holland
Martin Holland
PAPeter Andersen
Peter Andersen
FFFrank Follmann
Frank Follmann
Ocular and urogenital infections withChlamydia trachomatis (C.t.) are caused by a range of different serovars. The firstC.t. vaccine in clinical development (CTH522/CAF®01) induced neutralizing antibodies directed to the variable domain 4 (VD4) region of major outer membrane protein (MOMP), covering predominantly B and intermediate groups of serovars. The VD1 region of MOMP contains neutralizing B-cell epitopes targeting serovars of the C and C-related complex. Using an immuno-repeat strategy, we extended the VD1 region of SvA and SvJ to include surrounding conserved segments, extVD1Aand extVD1J, and repeated this region four times. The extVD1A*4 was most immunogenic with broad cross-surface and neutralizing reactivity against representative members of the C and C-related complex serovars. Importantly, in vitro results for extVD1A*4 translated into in vivo biological effects, demonstrated by in vivo neutralization of SvA and protection/cross-protection against intravaginal challenge with both SvA and the heterologous SvIa strain.